Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From an Open-Label Extension Study

被引：0

作者：

Hauser, Robert ^{[1
]}

Barkay, Hadas ^{[2
]}

Fernandez, Hubert ^{[3
]}

Factor, Stewart ^{[4
]}

Jimenez-Shahed, Joohi ^{[5
]}

Gross, Nicholas ^{[6
]}

Savola, Juha-Matti ^{[7
]}

Anderson, Karen E. ^{[8
]}

机构：

[1] Univ S Florida, Parkinsons Dis & Movement Disorders Ctr, Tampa, FL USA

[2] Teva Pharmaceut, Netanya, Israel

[3] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA

[4] Emory Univ, Atlanta, GA 30322 USA

[5] Baylor Coll Med, Houston, TX 77030 USA

[6] Teva Pharmaceut, Frazer, PA USA

[7] Teva Pharmaceut Int, Basel, Switzerland

[8] Georgetown Univ, Washington, DC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S4.009

引用

页数：4